Status:
TERMINATED
KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial
Lead Sponsor:
University of Alberta
Conditions:
Recurrent Acute Tonsillitis
Eligibility:
All Genders
3-15 years
Phase:
PHASE2
Brief Summary
Our group wishes to test the novel hypothesis that intraoperative use of ketorolac in pediatric patients undergoing tonsillectomy reduces post-operative nausea and vomiting, postoperative pain scores,...
Detailed Description
Intraoperative analgesia has a tremendous theoretical potential to decrease postoperative pain, and thus narcotic requirement and length of subsequent hospital stay. There is indeed a dearth of eviden...
Eligibility Criteria
Inclusion
- Patients aged 3yrs-15yrs who will undergo tonsillectomy or adeno-tonsillectomy for sleep disordered breathing confirmed by oximetry
Exclusion
- Severe Obstructive Sleep Apnea
- Co-morbid disease precluding use of NSAIDS or Narcotics
- Language/developmental/social inability to assess pain scores
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT01498796
Start Date
September 1 2009
End Date
July 1 2013
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stollery Children's Hospital
Edmonton, Alberta, Canada, T6G 2B7